Notable Labs

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Notable Labs sits in the upper half of US sponsors by registered trial count (#7,388 of 15,742 sponsors by registered trial count).

1 total trials none currently recruiting 1 completed upper half by trial count

Notable Labs: 1 sponsored US clinical trial, none currently recruiting.

Notable Labs sponsors 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 1 completed. The most-studied condition in this pipeline is Chronic Myelogenous Leukemia, with 1 trials.

Mid-pack sponsor footprint

Notable Labs is in the upper half of sponsors by trial count (#7,388 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.

Indexed trials (enrollment closed)

1 total, page 1 of 1

COMPLETED

Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy

NCT04014764

Therapeutic Areas

Chronic Myelogenous Leukemia 1
Myeloproliferative Neoplasm 1
Acute Myelogenous Leukemia 1
Multiple Myeloma 1
Acute Lymphoblastic Leukemia 1
Myelodysplastic Syndromes 1
Lymphoma 1

How the Notable Labs archive is shaped

1 indexed studies, none listed as recruiting (0% open); 1 completed (100%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Chronic Myelogenous Leukemia (1 trial), 6 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Notable Labs: archived-pipeline peers nationwide

Peers matched on 1 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Notable Labs sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%20%40%60% Total trials Recruiting share Notable Labs1200 Pharma1ST Biotherapeutics3 Waves Wellness3EO Health10xBio22nd Century Group23andMe3-C Institute for Social Development
Notable Labs sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Notable Labs sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Notable Labs page

1 registered trials is a research-attention snapshot, not an endorsement of Notable Labs or any single study.

  • None of Notable Labs's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Chronic Myelogenous Leukemia is the condition Notable Labs studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Chronic Myelogenous Leukemia trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Notable Labs pipeline card: 1 registered trials from official public datasets.Report a data error.